Top Markets
Coin of the day
Diagonal Bio AB (publ) Diagonal Bio AB (publ)

Diagonal Bio AB (publ)

DIABIO
Rank in Stocks #40963
Diagonal Bio AB is a Swedish biotechnology firm dedicated to advancing the... Diagonal Bio AB is a Swedish biotechnology firm dedicated to advancing the Panviral platform. This innovative technology is engineered to pinpoint and diagnose minute genetic fragments belonging to a range of pathogens, such as viruses, bacteria, and fungi. Established in 2020, the company's main operations are based in Lund, Sweden.
Share Price
$0.00143282
Last synced: 2025-04-14
Market Cap
$57.28K
Change (1 day)
0.03%
Change (1 year)
0.00%
Country
SE
Trade Diagonal Bio AB (publ) (DIABIO)

Category

Operating Margin for Diagonal Bio AB (publ) (DIABIO)
Operating Margin as of 2026 TTM: 0.00%
According to Diagonal Bio AB (publ) latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Diagonal Bio AB (publ) from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
38.97% -
US
28.81% -
NL
0.00% -
CH
0.00% -
KR
31.23% -
BE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.